Rank #172 · Healthcare
Zhong Huijuan
Pharmaceuticals · China
Net worth$16.7B
Today−$834M
7 days−$1.8M
30 days−$533M
Net worth, last 30 days
Low $16.7BHigh $19.0B
Biography
Zhong Huijuan is the chairman and CEO of Chinese drugmaker Hansoh Pharmaceutical Group, which produces oncology, psychoactive, antidiabetic and other drugs.
Zhong's husband, Sun Piaoyang, is also a billionaire and leads Jiangsu Hengrui Pharmaceuticals, which is dual-listed in Shanghai and Hong Kong.
Their daughter, Sun Yuan, is Hansoh's executive director.
Headquartered in the Chinese coastal city of Lianyungang, Hansoh went public on the Hong Kong Stock Exchange in 2019.
In 2026, the company announced a $15 billion deal where it will jointly develop several antibody drugs with Swiss multinational Roche. Hansoh also has billion-dollar deals with pharmaceutical giants including Merck.
Holdings
| Company | Ticker | Shares | Value |
|---|---|---|---|
| Hansoh Pharmaceutical Group | 3692-HK | 3,902,210,000 | $126.5B |
| Jiangsu Hengrui Medicine | 600276-CN | 110,750,000 | $5.2B |
| Private assets & other | $623M | ||